These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 11105276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN, Kumar S, Jain S, Bhattacharya SN.
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract] [Full Text] [Related]

  • 3. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 4. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R, Revankar CR, Pai VV, Kingsley S.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract] [Full Text] [Related]

  • 5. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR, Pai VV, Samy MS, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract] [Full Text] [Related]

  • 6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 7. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV, Bulchand HO, Revankar CR, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract] [Full Text] [Related]

  • 8. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D, López-García L, Neme-Yunes Y, Yuen-Palos R, Vega-Memije ME, Arenas R.
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract] [Full Text] [Related]

  • 9. Dapsone syndrome: an incomplete form.
    Jaswal R, Thami GP, Kanwar AJ.
    Indian J Lepr; 1998 Oct; 70(2):229-30. PubMed ID: 9724867
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP, Antia NH.
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.